{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T04:56:30Z","timestamp":1790571390376,"version":"4.1.0"},"reference-count":29,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T00:00:00Z","timestamp":1790553600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Nephrol."],"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Sequential emergence of anti-glomerular basement membrane (GBM) disease after anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) is rare.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Case presentation<\/jats:title>\n                    <jats:p>An 85-year-old woman presented with fever, edema, elevated myeloperoxidase (MPO)-ANCA, mild urinary abnormalities, markedly elevated urinary tubular injury markers, and negative serum anti-GBM antibodies measured by chemiluminescent enzyme immunoassay. Renal biopsy was not performed because of advanced age, severe dementia, antiplatelet therapy, and the family\u2019s preference for non-invasive management. She was clinically presumed to have AAV and achieved apparent clinical remission with prednisolone alone, although MPO-ANCA remained positive. However, 2.5 months after the initial AAV diagnosis, she developed rapidly progressive kidney failure requiring dialysis, accompanied by severe hematuria, increased proteinuria, urinary casts, and markedly elevated anti-GBM antibodies. Clinically diagnosed anti-GBM disease was treated with methylprednisolone pulse therapy, prednisolone, plasma exchange, and hemodialysis. Although renal recovery was not achieved, anti-GBM antibodies became negative, and she remained clinically stable on maintenance hemodialysis for over 4 years while receiving low-dose prednisolone.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>This case suggests that anti-GBM disease can emerge shortly after apparent clinical remission of AAV. ANCA-mediated GBM injury and age-related GBM changes may contribute to subsequent anti-GBM autoimmunity, although these mechanisms remain hypothetical in this patient. Prompt anti-GBM antibody testing should be considered when a rapid, unexplained decline in kidney function occurs during or after AAV treatment.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fneph.2026.1967122","type":"journal-article","created":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T04:29:38Z","timestamp":1790569778000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Anti-GBM disease shortly after clinically presumed ANCA-associated vasculitis in an 85-year-old patient: a case report and literature review"],"prefix":"10.3389","volume":"6","author":[{"given":"Hiroki","family":"Ito","sequence":"first","affiliation":[{"name":"Division of Nephrology and Hypertension, Faculty of Medicine, Tohoku Medical and Pharmaceutical University","place":["Sendai, Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiyu","family":"Abe","sequence":"additional","affiliation":[{"name":"Division of Nephrology and Hypertension, Faculty of Medicine, Tohoku Medical and Pharmaceutical University","place":["Sendai, Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuya","family":"Suzuki","sequence":"additional","affiliation":[{"name":"Division of Nephrology and Hypertension, Faculty of Medicine, Tohoku Medical and Pharmaceutical University","place":["Sendai, Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kentaro","family":"Yano","sequence":"additional","affiliation":[{"name":"Division of Nephrology and Hypertension, Faculty of Medicine, Tohoku Medical and Pharmaceutical University","place":["Sendai, Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fumiya","family":"Sato","sequence":"additional","affiliation":[{"name":"Division of Nephrology and Hypertension, Faculty of Medicine, Tohoku Medical and Pharmaceutical University","place":["Sendai, Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takaki","family":"Numahata","sequence":"additional","affiliation":[{"name":"Division of Nephrology and Hypertension, Faculty of Medicine, Tohoku Medical and Pharmaceutical University","place":["Sendai, Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Risa","family":"Ishikawa","sequence":"additional","affiliation":[{"name":"Division of Nephrology and Hypertension, Faculty of Medicine, Tohoku Medical and Pharmaceutical University","place":["Sendai, Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akari","family":"Endo-Matsumoto","sequence":"additional","affiliation":[{"name":"Division of Nephrology and Hypertension, Faculty of Medicine, Tohoku Medical and Pharmaceutical University","place":["Sendai, Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keiji","family":"Matsumoto","sequence":"additional","affiliation":[{"name":"Division of Nephrology and Hypertension, Faculty of Medicine, Tohoku Medical and Pharmaceutical University","place":["Sendai, Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tsubasa","family":"Yuki","sequence":"additional","affiliation":[{"name":"Division of Nephrology and Hypertension, Faculty of Medicine, Tohoku Medical and Pharmaceutical University","place":["Sendai, Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayaka","family":"Kamada","sequence":"additional","affiliation":[{"name":"Division of Nephrology and Hypertension, Faculty of Medicine, Tohoku Medical and Pharmaceutical University","place":["Sendai, Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideaki","family":"Hashimoto","sequence":"additional","affiliation":[{"name":"Division of Nephrology and Hypertension, Faculty of Medicine, Tohoku Medical and Pharmaceutical University","place":["Sendai, Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Go","family":"Anan","sequence":"additional","affiliation":[{"name":"Division of Nephrology and Hypertension, Faculty of Medicine, Tohoku Medical and Pharmaceutical University","place":["Sendai, Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katsuya","family":"Ishiyama","sequence":"additional","affiliation":[{"name":"Division of Nephrology and Hypertension, Faculty of Medicine, Tohoku Medical and Pharmaceutical University","place":["Sendai, Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takuo","family":"Hirose","sequence":"additional","affiliation":[{"name":"Division of Nephrology and Hypertension, Faculty of Medicine, Tohoku Medical and Pharmaceutical University","place":["Sendai, Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takefumi","family":"Mori","sequence":"additional","affiliation":[{"name":"Division of Nephrology and Hypertension, Faculty of Medicine, Tohoku Medical and Pharmaceutical University","place":["Sendai, Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,9,28]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1053\/j.ajkd.2005.05.003","article-title":"Coexistence of anti-glomerular basement membrane antibodies and myeloperoxidase-ANCAs in crescentic glomerulonephritis","volume":"46","author":"Rutgers","year":"2005","journal-title":"Am J Kidney Dis"},{"key":"B2","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1016\/j.kint.2017.03.014","article-title":"Patients double-seropositive for ANCA and anti-GBM antibodies have varied renal survival, frequency of relapse, and outcomes compared to single-seropositive patients","volume":"92","author":"McAdoo","year":"2017","journal-title":"Kidney Int"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1002\/ccr3.4553","article-title":"Sequential development of ANCA-associated vasculitis and anti-GBM disease: a report of two cases","volume":"9","author":"Le Moine","year":"2021","journal-title":"Clin Case Rep"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1053\/j.ajkd.2003.11.019","article-title":"Sequential development of perinuclear ANCA-associated vasculitis and anti-glomerular basement membrane glomerulonephritis","volume":"43","author":"Serratrice","year":"2004","journal-title":"Am J Kidney Dis"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1007\/s13730-022-00758-3","article-title":"Anti-glomerular basement membrane disease developing 3 years after the development of Sweet syndrome and 1 year after the development of anti-neutrophil cytoplasmic antibody-associated vasculitis: a case report","volume":"12","author":"Matsuno","year":"2023","journal-title":"CEN Case Rep"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1016\/S0046-8177(87)80340-4","article-title":"Coexistent Wegener's granulomatosis and anti-glomerular basement membrane disease","volume":"18","author":"Wahls","year":"1987","journal-title":"Hum Pathol"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1093\/omcr\/omw026","article-title":"Sequential occurrence of anti-glomerular basement membrane disease 9 years after anti-neutrophil cytoplasmic antibody-associated vasculitis","volume":"2016","author":"Chan","year":"2016","journal-title":"Oxf Med Case Rep"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1136\/pgmj.2007.062752","article-title":"Importance of checking anti-glomerular basement membrane antibody status in patients with anti-neutrophil cytoplasmic antibody-positive vasculitis","volume":"84","author":"Gallagher","year":"2008","journal-title":"Postgrad Med J"},{"key":"B9","article-title":"A case of rapidly progressive glomerulonephritis with anti-glomerular basement membrane antibody in the course of MPO-ANCA positive interstitial pneumonia","volume":"54","author":"Yamazaki","year":"2012","journal-title":"Nihon Jinzo Gakkai Shi"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1053\/j.ajkd.2009.07.015","article-title":"Development of anti-glomerular basement membrane disease after remission from perinuclear ANCA-associated glomerulonephritis in a patient with HLA susceptibility","volume":"55","author":"O'Connor","year":"2010","journal-title":"Am J Kidney Dis"},{"key":"B11","article-title":"Rapidly progressing glomerulonephritis. Microangiitis associated with antibodies against the glomerular basement membrane","volume":"157","author":"Randl\u00f8v","year":"1995","journal-title":"Ugeskr Laeger"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.4009\/jsdt.44.463","article-title":"A case of rapidly progressive glomerulonephritis with both MPO-ANCA and anti-GBM antibodies complicated by thrombotic thrombocytopenic purpura","volume":"44","author":"Yoshihara","year":"2011","journal-title":"Nihon Toseki Igakkai Zasshi"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2024.103531","article-title":"Epidemiology, clinical features, risk factors, and outcomes in anti-glomerular basement membrane disease: A systematic review and meta-analysis","volume":"23","author":"Kuang","year":"2024","journal-title":"Autoimmun Rev"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0910500","article-title":"Molecular architecture of the Goodpasture autoantigen in anti-GBM nephritis","volume":"363","author":"Pedchenko","year":"2010","journal-title":"N Engl J Med"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1007\/s10157-014-1073-z","article-title":"The level of urinary \u03b11 microglobulin excretion is a useful marker of peritubular capillaritis in antineutrophil cytoplasmic antibody associated vasculitis","volume":"19","author":"Ohashi","year":"2015","journal-title":"Clin Exp Nephrol"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1007\/s10157-009-0200-8","article-title":"Tubulointerstitial nephritis without glomerular lesions in three patients with myeloperoxidase-ANCA-associated vasculitis","volume":"13","author":"Nakabayashi","year":"2009","journal-title":"Clin Exp Nephrol"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1080\/0886022X.2024.2323160","article-title":"Coexistence of anti-glomerular basement membrane disease and IgA nephropathy: an illustrative case and comprehensive literature review","volume":"46","author":"Chen","year":"2024","journal-title":"Ren Fail"},{"key":"B18","article-title":"Autoantibodies to myeloperoxidase aggravate mild anti-glomerular-basement-membrane-mediated glomerular injury in the rat","volume":"149","author":"Heeringa","year":"1996","journal-title":"Am J Pathol"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.87.11.4115","article-title":"Anti-neutrophil cytoplasmic autoantibodies induce neutrophils to degranulate and produce oxygen radicals in vitro","volume":"87","author":"Falk","year":"1990","journal-title":"Proc Natl Acad Sci USA"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2020101442","article-title":"Identification of an altered matrix signature in kidney aging and disease","volume":"32","author":"Randles","year":"2021","journal-title":"J Am Soc Nephrol"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1053\/j.ackd.2010.05.002","article-title":"The aging kidney: physiological changes","volume":"17","author":"Weinstein","year":"2010","journal-title":"Adv Chronic Kidney Dis"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25126585","article-title":"Kidney aging and chronic kidney disease","volume":"25","author":"Zhang","year":"2024","journal-title":"Int J Mol Sci"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1016\/j.kint.2026.03.029","article-title":"Anti-glomerular basement membrane disease: variant forms and underlying mechanisms","volume":"110","author":"Kuang","year":"2026","journal-title":"Kidney Int"},{"key":"B24","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1016\/j.kint.2021.05.021","article-title":"KDIGO 2021 clinical practice guideline for the management of glomerular diseases","volume":"100","year":"2021","journal-title":"Kidney Int"},{"key":"B25","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1093\/ndt\/gfaf190","article-title":"Anti-glomerular basement membrane disease\u2014treatment standard","volume":"41","author":"McAdoo","year":"2026","journal-title":"Nephrol Dial Transplant"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2022050581","article-title":"Risk stratification to predict renal survival in anti-glomerular basement membrane disease","volume":"34","author":"Floyd","year":"2023","journal-title":"J Am Soc Nephrol"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1016\/j.ekir.2023.12.011","article-title":"Evaluation of the risk prediction models in predicting kidney outcomes in antiglomerular basement membrane disease","volume":"9","author":"Kuang","year":"2024","journal-title":"Kidney Int Rep"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1159\/000518362","article-title":"Accuracy of anti-GBM antibodies in diagnosing anti-glomerular basement membrane disease: a systematic review and meta-analysis","volume":"52","author":"Shiroshita","year":"2021","journal-title":"Am J Nephrol"},{"key":"B29","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1253\/circj.CJ-19-0773","article-title":"JCS 2017 guideline on management of vasculitis syndrome\u2014Digest version","volume":"84","author":"Isobe","year":"2020","journal-title":"Circ J"}],"container-title":["Frontiers in Nephrology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneph.2026.1967122\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T04:29:39Z","timestamp":1790569779000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneph.2026.1967122\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,28]]},"references-count":29,"alternative-id":["10.3389\/fneph.2026.1967122"],"URL":"https:\/\/doi.org\/10.3389\/fneph.2026.1967122","relation":{},"ISSN":["2813-0626"],"issn-type":[{"value":"2813-0626","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,28]]},"article-number":"1967122"}}